ArticleCell transplantation

An exploration of the initiation time and patient selection of PD-1 inhibitors/PD-1 inhibitors combined with chemotherapy as salvage therapy in R/R DLBCL patients after anti-CD19-CAR T-cell therapy.

Xin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.